Nevertheless, the disease progression wasslower and showed significant improvements in motor performance, indicatingthat TDP-43A315T mice treated with MSN-LEP-PIO seem to have less energy demand in the late stage of the symptomsof ALS. The gene discussed is LEP; the disease is amyotrophic lateral sclerosis.